These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


406 related items for PubMed ID: 16510574

  • 1. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
    Shin SR, Sánchez-Velar N, Sherr DH, Sonenshein GE.
    Cancer Res; 2006 Mar 01; 66(5):2570-5. PubMed ID: 16510574
    [Abstract] [Full Text] [Related]

  • 2. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
    Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE.
    Mol Cell Biol; 2005 Nov 01; 25(22):10136-47. PubMed ID: 16260626
    [Abstract] [Full Text] [Related]

  • 3. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
    Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE.
    Cancer Res; 2005 Dec 15; 65(24):11375-83. PubMed ID: 16357145
    [Abstract] [Full Text] [Related]

  • 4. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
    Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE.
    J Clin Invest; 1997 Dec 15; 100(12):2952-60. PubMed ID: 9399940
    [Abstract] [Full Text] [Related]

  • 5. Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells.
    Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE.
    Carcinogenesis; 2000 May 15; 21(5):871-9. PubMed ID: 10783306
    [Abstract] [Full Text] [Related]

  • 6. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype.
    Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE.
    Cancer Res; 2007 Dec 15; 67(24):11742-50. PubMed ID: 18089804
    [Abstract] [Full Text] [Related]

  • 7. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T.
    J Clin Invest; 2004 Aug 15; 114(4):569-81. PubMed ID: 15314694
    [Abstract] [Full Text] [Related]

  • 8. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
    Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE.
    Mol Cell Biol; 2003 Aug 15; 23(16):5738-54. PubMed ID: 12897145
    [Abstract] [Full Text] [Related]

  • 9. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
    Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE.
    Cancer Res; 2001 May 01; 61(9):3810-8. PubMed ID: 11325857
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE.
    Cancer Res; 2002 Nov 15; 62(22):6770-8. PubMed ID: 12438279
    [Abstract] [Full Text] [Related]

  • 11. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
    Sovak MA, Arsura M, Zanieski G, Kavanagh KT, Sonenshein GE.
    Cell Growth Differ; 1999 Aug 15; 10(8):537-44. PubMed ID: 10470853
    [Abstract] [Full Text] [Related]

  • 12. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion.
    Liu M, Sakamaki T, Casimiro MC, Willmarth NE, Quong AA, Ju X, Ojeifo J, Jiao X, Yeow WS, Katiyar S, Shirley LA, Joyce D, Lisanti MP, Albanese C, Pestell RG.
    Cancer Res; 2010 Dec 15; 70(24):10464-73. PubMed ID: 21159656
    [Abstract] [Full Text] [Related]

  • 13. The role of NF-kappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis.
    Mann KK, Doerre S, Schlezinger JJ, Sherr DH, Quadri S.
    Mol Pharmacol; 2001 Feb 15; 59(2):302-9. PubMed ID: 11160867
    [Abstract] [Full Text] [Related]

  • 14. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.
    Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H.
    Oncogene; 2007 Feb 01; 26(5):711-24. PubMed ID: 16862183
    [Abstract] [Full Text] [Related]

  • 15. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.
    Belguise K, Sonenshein GE.
    J Clin Invest; 2007 Dec 01; 117(12):4009-21. PubMed ID: 18037997
    [Abstract] [Full Text] [Related]

  • 16. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
    Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE.
    Oncogene; 2000 Nov 16; 19(48):5498-506. PubMed ID: 11114727
    [Abstract] [Full Text] [Related]

  • 17. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.
    Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE.
    Nat Cell Biol; 2007 Apr 16; 9(4):470-8. PubMed ID: 17369819
    [Abstract] [Full Text] [Related]

  • 18. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
    Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE.
    Oncogene; 2001 Mar 15; 20(11):1287-99. PubMed ID: 11313873
    [Abstract] [Full Text] [Related]

  • 19. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
    Bendinelli P, Matteucci E, Maroni P, Desiderio MA.
    Mol Cancer Res; 2009 Aug 15; 7(8):1328-41. PubMed ID: 19671685
    [Abstract] [Full Text] [Related]

  • 20. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME, Schmah O, Pollock AD, Hoffmann A, Gilmore TD.
    Oncogene; 2005 Sep 29; 24(43):6574-83. PubMed ID: 16027734
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.